BD GENERICS ApS: Financial statements 2024
CVR: 28707207
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -110,648 and a net result of DKK -61,196 compared with DKK -64,095 the year before. Equity in the 2024 report amounted to DKK 702,958. The solvency ratio was 70.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -110,648
- Profit/Loss
- DKK -61,196
- Equity
- DKK 702,958
- Total Assets
- DKK 994,569
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -111 t. | -61 t. | 703 t. | - |
| 2023 | 0 | -101 t. | -64 t. | 764 t. | - |
| 2022 | 0 | -70 t. | -44 t. | 828 t. | - |
| 2021 | 0 | -7 t. | -13 t. | 872 t. | - |
| 2020 | - | -9 t. | -14 t. | 885 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.